Back |
home / stock / flgt / flgt message board
Subject | By | Source | When |
---|---|---|---|
$FLGT is back in action...long and strong. This | TrendTrade2016 | investorshub | 10/05/2019 9:33:39 AM |
Genomics are the future. We will never cure | TrendTrade2016 | investorshub | 09/08/2019 10:50:25 AM |
The science looks good here to me. Reminds me | Reversemergers | investorshub | 09/08/2019 2:48:00 AM |
$FLGT get ready for the bio sensation of | TrendTrade2016 | investorshub | 09/06/2019 6:20:42 PM |
$FLGT ready to take on 13 buckaroos!! | TrendTrade2016 | investorshub | 09/05/2019 7:38:39 PM |
Nice buying opportunity here today. | Reversemergers | investorshub | 08/30/2019 5:36:37 PM |
Got a piece of this nice looking pie. | Reversemergers | investorshub | 08/23/2019 4:59:33 PM |
$FLGT what bio beast. The power of the | TrendTrade2016 | investorshub | 08/23/2019 9:04:24 AM |
$FLGT here comes 13.00 boom!! so lovely...the stock | TrendTrade2016 | investorshub | 08/22/2019 6:17:50 PM |
$FLGT here we go..without doubt we are heading | TrendTrade2016 | investorshub | 08/21/2019 5:54:54 PM |
$FLGT getting set for next attack | TrendTrade2016 | investorshub | 08/19/2019 5:53:01 PM |
$FLGT here we go to 13.00. What a | TrendTrade2016 | investorshub | 08/12/2019 3:40:00 PM |
$FLGT is going to turn out like CSBR | TrendTrade2016 | investorshub | 08/10/2019 8:36:06 AM |
$FLGT breaking 10 buckaroos on blow out earnings. | TrendTrade2016 | investorshub | 08/07/2019 11:21:54 AM |
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
2024-07-01 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT) and a leading nanobiotechnology company specializing in innovative cancer therapeutics, today announced that Phase 1 clinical data on its lead therapeutic development candidate, FID-007, to treat Head and Neck cancer, was prese...